Search Results - B. Altmann

64 | NIVOLUMAB + GemOx AS SECOND‐LINE THERAPY FOR PERIPHERAL T CELL LYMPHOMA IN TRANSPLANT‐INELIGIBLE PATIENTS: FINAL ANALYSIS OF A SUB‐COHORT OF THE RANDOMIZED NIVEAU TRIAL by G. Held, B. Altmann, L. de Leval, M. Dreyling, A. Kerkhoff, T. Gastinne, M. André, F. Offner, T. Weber, S. Wirths, R. Casasnovas, G. Cartron, C. Bonnet, L. Thurner, S. Mayer, G. Illerhaus, T. Illmer, S. Vigouroux, F. Morschhauser, V. Safar, A. Dąbrowska‐Iwanicka, M. Gomes da Silva, P. Gaulard, T. J. Molina, A. Rosenwald, R. Greil, U. Jaeger, A. Avigdor, M. Löffler, M. Ziepert, C. Haioun, V. Poeschel, R. Houot

Get full text

156 | EXCELLENT OUTCOME WITH INTERIM PET ADAPTED TREATMENT REDUCTION IN ELDERLY DLBCL PTSWITH FAVOURABLE PROGNOSIS: RESULTS OF 288 PTS TREATED IN OPTIMAL > 60 OF THE DSHNHL/GLA by L. Thurner, B. Altmann, G. Held, A. Neubauer, J. Bittenbring, A. Viardot, M. Hänel, R. Mahlberg, S. Wirths, M. Dreyling, T. Gaska, U. Langenkamp, U. Keller, A. Kiani, K. Hübel, J. Hasenkamp, H. Höffkes, A. Elmaagacli, T. Illmer, A. Rank, P. Staib, K. Wille, L. Müller, H. Hebart, F. Griesinger, B. Glass, M. Nickelsen, N. Schmitz, L. Trümper, M. Löffler, A. Hasse, V. Lesan, O. Cetin, N. Murawski, M. Bewarder, D. Kaddu‐Mulindwa, I. Kos, K. Christofyllakis, G. Schneider, C. Berdel, D. Hellwig, M. Ziepert, V. Pöschel

Get full text

157 | PET GUIDED OMISSION OF RADIOTHERAPY IN ELDERLY DLBCL PTS WITH LESS FAVOURABLE PROGNOSIS IS SAFE: RESULTS OF 863 PATIENTS TREATED IN THE OPTIMAL > 60 TRIAL OF THE DSHNHL/GLA by L. Thurner, B. Altmann, G. Held, M. Hänel, A. Viardot, A. Neubauer, J. Bittenbring, J. Hasenkamp, S. Wirths, M. Dreyling, K. Hübel, H. Kirchen, J. Dierlamm, K. Habersang, R. Mahlberg, U. Keller, H. Höffkes, T. Illmer, F. Griesinger, U. Langenkamp, T. Gaska, A. Elmaagacli, M. Schatz, N. Frickhofen, A. Kiani, P. Staib, H. Hebart, B. Glass, M. Nickelsen, N. Schmitz, L. Trümper, M. Löffler, A. Hasse, V. Lesan, O. Cetin, N. Murawski, M. Bewarder, D. Kaddu‐Mulindwa, I. Kos, K. Christofyllakis, G. Schneider, C. Berdel, D. Hellwig, M. Ziepert, V. Poeschel

Get full text

159 | R‐POLA‐GLO – CHEMO‐LIGHT FRONTLINE THERAPY INDUCES HIGH RESPONSE RATES WITH A FAVORABLE SAFETY PROFILE IN ELDERLY/FRAIL PATIENTS WITH AGGRESSIVE LYMPHOMA by R. Wurm‐Kuczera, T. Melchardt, P. Pichler, A. Huster, A. Kerkhoff, M. Panny, R. Schroers, A. Ossami Saidy, F. Müller, F. Damm, M. Orlinger, P. Staber, C. Schwaenen, R. Michael, L. Wohn, C. Schmitt, M. Hoffman, M. Hänel, J. Düll, S. Heyn, S. Mayer, T. Weber, P. Reimer, N. Rotter, U. Schnetzke, B. von Tresckow, G. Kammerer, J. Rasvina, B. Lehner, T. Mika, D. Böckle, C. Leng, A. L. Illert, B. Altmann, B. Friedrichs, E. Willenbacher, D. Mougiakakos, C. Pott, S. Al‐Batran, A. Rosenwald, D. Hellwig, S. Dietrich, B. Glass, G. Lenz, U. Keller, M. Ziepert, R. Greil, B. Chapuy

Get full text